Miao Su
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Nanocomposite Films for Food Packaging
Papers in
-
- RNA Interference and Gene Delivery 4
-
- Nanoplatforms for cancer theranostics 8
- Co-authors
- Edouard C. Nice (4 shared papers)Xianzhu Yang (9 shared papers)Jie Lin (1 shared paper)Na Xie (1 shared paper)Wenhui Zhang (1 shared paper)Wei Gao (1 shared paper)Peijie Wu (1 shared paper)Yueqiang Zhu (3 shared papers)
- Journals
- Frontiers in Oncology (3 papers)RSC Advances (2 papers)Frontiers in Genetics (2 papers)Cancers (2 papers)Advanced Materials (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Miao Su
43 papers receiving 653 citations
Peers
Comparison fields: 5 of 101
- Biomaterials 133
- Cancer Research 73
- Immunology 90
- Molecular Medicine 20
- Oncology 96
Countries citing papers authored by Miao Su
This map shows the geographic impact of Miao Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miao Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miao Su more than expected).
Fields of papers citing papers by Miao Su
This network shows the impact of papers produced by Miao Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miao Su. The network helps show where Miao Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Miao Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 157 | |
| 2 | 2021 | 56 | |
| 3 | 2022 | 46 | |
| 4 | 2023 | 45 | |
| 5 | 2017 | 41 | |
| 6 | 2023 | 39 | |
| 7 | 2024 | 33 | |
| 8 | 2023 | 21 | |
| 9 | 2021 | 19 | |
| 10 | 2024 | 16 | |
| 11 | 2023 | 14 | |
| 12 | 2021 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2023 | 9 | |
| 17 | 2024 | 9 | |
| 18 | 2021 | 8 | |
| 19 | 2023 | 8 | |
| 20 | 2021 | 8 |
About Miao Su
Miao Su is a scholar working on Molecular Biology, Biomedical Engineering, Immunology, Biomaterials and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 657 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (4 papers), Innovative concrete reinforcement materials (3 papers), Immune cells in cancer (3 papers), Nanocomposite Films for Food Packaging (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Advanced Nanomaterials in Catalysis (3 papers). The work is most often cited by research in Biomaterials (133 citations), Cancer Research (73 citations), Immunology (90 citations), Molecular Medicine (20 citations) and Oncology (96 citations). Miao Su has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Edouard C. Nice, Xianzhu Yang, Jie Lin, Na Xie, Wenhui Zhang, Wei Gao, Peijie Wu, Yueqiang Zhu, Li Zhou and Canhua Huang. Their work appears in journals such as Frontiers in Oncology, RSC Advances, Frontiers in Genetics, Cancers and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.